A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
No official summary available for this bill.
Received in the Senate.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line